TAINFUCHEM: lurasidone CAS NO.367514-87-2

Min.Order Quantity:: 1 Kilogram

Purity:: 99% min

Port:: SHANGHAI,PORT

Payment Terms:: L/C,D/P

Add to Inquiry Cart

Product Details

Keywords

lurasidone
lurasidone
367514-87-2

Quick Details

ProName: TAINFUCHEM: lurasidone
CasNo: 367514-87-2
Molecular Formula: C28H36N4O2S
Appearance: white crystaline powder
Application: For Organic Synthesis use
DeliveryTime: Prompt
PackAge: As per buyers'
Port: SHANGHAI,PORT
ProductionCapacity: 10 Metric Ton/Month
Purity: 99% min
Storage: In Room Temperature
Transportation: by sea or air
LimitNum: 1 Kilogram
N/M: N/M

Superiority

product name: lurasidone
synonyms: lurasidone;(3ar,4s,7r,7as)-2-[[(1r,2r)-2-[[4-(1,2-benzisothiazol-3-yl)-1-piperazinyl]methyl]cyclohexyl]methyl]hexahydro-4,7-methano-1h-isoindole-1,3(2h)-dione;4-{[(1r,2r)-2-{[4-(2$l^{4}-thia-6-azatricyclo[5.4.0.0^{2,6}]undeca-1(11),2,4,7,9-pentaen-5-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}-4-azatricyclo[5.2.1.0^{2,6}]deca-1(9),2(6),7-triene-3,5-dione;lurasidone (sm13496);(3ar,4s,7r,7as)-2-{[(1r,2r)-2-{[4-(1,2-benzothiazol-3-yl)piperazin-1-yl]methyl}cyclohexyl]methyl}hexahydro-1h-4,7-methanoisoindole-1,3(2h)-dione;urasidone;lurasidone, >=98%
cas: 367514-87-2
mf: c28h36n4o2s
mw: 0
einecs:
product categories: pharmaceutical intermediate
mol file: mol file

Details

lurasidone is developed by japan's dainippon sumitomo pharma which is an atypical antipsychotic,and is a classification of drug registration 3.1 class, it is suitable for the treatment of patients with schizophrenia. its efficacy is determined in four six weeks in adult patients with schizophrenia controlled studies. the exact mechanism of the treatment of schizophrenia, like other atypical antipsychotics ,is not very clear,and may be related to the antagonism of the dopamine d2 and serotonin 2a (5-ht2a) receptors. for the treatment of schizophrenia, a study has reported lurasidone can improve cognitive function.
october 28, 2010 ,the fda approved lurasidone hydrochloride (lurasidone hci) tablets once a day for the first-line treatment of patients with schizophrenia, the trade name is latuda.
dosage: the recommended starting dose is 40 mg / d, the effective dose range is 40 ~ 120 mg /· d, the maximum recommended dose is 80 mg /· d. it should be taken with food.
adverse reaction: common adverse reactions are somnolence, akathisia, nausea, parkinson's disease-like symptoms and emotional anxiety. lurasidone has no physical dependence, less likely to cause weight gain, it does not cause glucose, lipids (lipids), it changs the period between ecg and qt.
the above information is edited by the chemicalbook of tian ye.

Post a RFQ

Cas No.:

Product Name:

Quantity: